Navigation Links
Nexicon Technology to Protect Healthcare Industry

LOS ANGELES, July 28 /PRNewswire-FirstCall/ -- Nexicon (Pink Sheets: NXCO), developer of next generation digital media protection and intelligence solutions, today announced its intention to market its revolutionary MARC(TM) technology platform to ensure network protection and data security for the growing needs of the healthcare industry - including insurance companies, pharmaceutical companies, hospitals, physician practices, and more. In furtherance of its plan, the company has retained the advisory services of Dr. Barry Markman, a renowned surgeon, inventor and entrepreneur with a strong background and expansive contacts throughout the medical community.

The entry into the healthcare field represents a natural expansion in the deployment of the MARC technology, which is capable of providing actionable intelligence and rights-enforcement capability to virtually any vertical market. Nexicon has successfully deployed its technology to aid rights holders in the fields of music, film, software and entertainment and is extending its capabilities to monitor corporate and organizational networks for serious security breaches.

What is MARC?

Nexicon's MARC technology accurately monitors, analyzes and reports on the integrity of data transmitted and stored on corporate networks. Every second, vast amounts of data are collected and transmitted throughout the healthcare industry, and it is absolutely critical for those handling that data to vigilantly protect against risk of data loss or security breach.

Federal and state regulations (including HIPAA and others) impose strict requirements on such data, and even a single incident of compromised information can have drastic ramifications. The consequences for noncompliance with HIPAA security regulations can be substantial, with penalties reaching into the millions of dollars for an offending organization.

In addition, pharmaceutical companies, universities and medical centers invest untold millions in the conduct of clinical trials, and a basic premise is that such information remains private and secure. A solitary unauthorized user operating a peer-to-peer (P2P) network, such as file sharing, instant messaging, or even just sending an email, can expose such data and cause millions in damage, in addition to compromising the privacy of patient health records.

MARC technology monitors and identifies such risks, without recording or storing the actual underlying data. Moreover, MARC doesn't require access to the confidential data that it monitors. The analyzed data remains exclusively within the client's proprietary network or "closed garden." The solution is revolutionary, cost-effective, simple to deploy, and a highly effective means of improving the data security portfolio of any hospital, health care facility, pharmaceutical company, or clinical testing firm.

"Even the most seemingly secure corporate networks are often found to be unknowingly hosting pirated content and sometimes illegal data," said Tommy Stiansen, chief technology officer of Nexicon. "Every time someone accesses that content, those networks are at risk. It's a simple fact that many corporate servers are actually zombies for content accessed by P2P and other users. With MARC in place, this risk is mitigated completely."

"At its core, our technology is focused on monitoring the activity of large amounts of data, and reporting on that information in an easy-to-understand, useful fashion," added Stiansen. "The healthcare industry is just one example, albeit an incredibly large one, where there are gigantic amounts of data being accessed under conditions of absolute privacy and security - and that's precisely the environment where MARC shines."

About Dr. Markman

Nexicon's initial efforts in the healthcare market will be led by Dr. Barry Markman. Dr. Markman, a graduate of NYU Medical School, is a surgeon, an entrepreneur and a named inventor on various issued and pending patents. He is the author of several articles, has presented at numerous professional conventions, and has made several television appearances. Dr. Markman also received his MBA from UNLV, with a concentration in venture capital. He has extensive experience with the conduct of clinical trials and emerging businesses. Dr. Markman will use his experience, knowledge and contacts to jumpstart Nexicon's initial efforts in the healthcare market.

"I'm very much looking forward to helping establish Nexicon's foothold in the healthcare industry," said Dr. Markman. "There are a myriad of potential applications for MARC, which will not only aid in regulatory compliance and loss mitigation, but will also ultimately promote overall privacy, safety, and economic efficiency. The opportunities are tremendous, and the need for MARC's capabilities continues to grow as the healthcare industry continues to maintain the integrity of highly sensitive data."

About Nexicon

Headquartered in Los Angeles, CA, Nexicon (PNK: NXCO) delivers next-generation digital media protection and digital media business intelligence products and solutions to many industries, including the motion picture and music industries, software and games, publishing, ISPs, financial services and government. It's product line includes: DigitalRanger to identify those who illegally facilitate, promote, and profit from hosting or distributing copyrighted content; GetAmnesty that allows copyright holders to fight piracy and collect revenue lost from illegal downloads; YouScout that helps content owners store, distribute and manage their content on the most popular community-driven sites on the Internet, such as YouTube(TM); Envoy that helps ISPs manage DMCA notices for their subscribers; and more. For more information about Nexicon, visit and check out Nexicon's blog at

Safe Harbor Statement

This release contains statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of the Company, its directors or its officers with respect to, among other things: (i) the Company's financing plans; (ii) trends affecting the Company's financial condition or results of operations; (iii) the Company's growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend," and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Tommy Stiansen

Sam Glines

SOURCE Nexicon
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Independence Blue Cross Harnesses Technology to Connect the Dots on Patient Care
2. Premier Visiting Nurse Selects Cardiocom Telehealth Technology
3. Cold Laser Technology Made Even More Accessible with Powerful New Product Available from Laser-Therapy.US
4. Teamwork, Technology, and Coordinated Care Improve Outcomes and Lower Costs
5. Align Technology Announces Second Quarter Fiscal 2009 Results
6. INHS Brings Health Information Technology Conference to Spokane
7. St. John's Hospital Acquires Latest Technology in Robotic-Assisted Surgery
8. ConvaTec Launches Hydrofiber(R) Technology Web Site
9. Align Technology Provides Update on Patent Litigation with Ormco Corporation
10. Healthy Advice Networks Announces the Launch of PracticeWire; Technology to Deliver Real-time Healthcare Content to Physicians
11. Norwell VNA and Hospice Selects Cardiocom Telehealth as Its New Technology Vendor
Post Your Comments:
(Date:10/13/2017)... ... October 13, 2017 , ... ... viewers the lowdown on sciatica in a new episode of "Success Files," which ... current events and innovation and investigates each subject in-depth with passion and integrity. ...
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of ... Philippines. “The Journey: From the Mountains to the Mission Field” is the creation of ... taught all ages and currently teaches a class of ladies at her church, which ...
(Date:10/12/2017)... ... 2017 , ... First Healthcare Compliance (FHC), an industry leader ... range of technology and learning solutions at the 68th Annual American Healthcare Association ... held October 14–18, 2017 at the Mandalay Bay Resort in Las Vegas, Nevada. ...
(Date:10/12/2017)... , ... October 12, 2017 , ... Planet Fitness, one ... U.S., announced today its plans to open a flagship location in Covington, LA at ... former Rooms To Go store next to Office Depot in the Holiday Square shopping ...
(Date:10/12/2017)... CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... cold therapy products, announced today the introduction of an innovative new design of the ... multipurpose pad so you get maximum comfort while controlling your pain while using cold ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... , Sept. 27, 2017  Commended for their devotion ... notable awards. Ranked as number one in the South Florida ... time in Inc. 5000 yearly list, the national specialty pharmacy ... Armando Bardisa will soon be honored by SFBJ ... Set to receive his award in ...
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
Breaking Medicine Technology: